Table 1.
Patient Demographics and Tumor Characteristics
| Patient characteristic | Overall Na(%)b(N = 2454) | Cured Na(%)b(n = 2222) | Recurrent disease Na(%)b(n = 95) | Persistent disease Na(%)b(n = 137) |
|---|---|---|---|---|
| Age at diagnosis (years) | ||||
| ≤44 | 863 (38.3) | 755 (37.1) | 50 (56.3) | 58 (44.5) |
| 45–54 | 596 (23.5) | 542 (23.6) | 21 (21.0) | 33 (23.3) |
| 55–64 | 564 (21.6) | 529 (22.4) | 11 (11.0) | 24 (16.9) |
| ≥65 | 431 (16.6) | 396 (16.9) | 13 (11.7) | 22 (15.3) |
| Sex | ||||
| Female | 1899 (77.7) | 1730 (78.1) | 73 (79.3) | 96 (70.3) |
| Male | 555 (22.3) | 492 (21.9) | 22 (20.7) | 41 (29.7) |
| Race | ||||
| White | 1857 (72.3) | 1678 (72.2) | 78 (79.0) | 101 (69.8) |
| Non-white/multiracial | 595 (27.7) | 542 (27.8) | 17 (21.0) | 36 (30.2) |
| Ethnicity | ||||
| Non-Hispanic | 1971 (78.5) | 1805 (79.5) | 60 (59.2) | 106 (75.9) |
| Hispanic | 483 (21.5) | 417 (20.5) | 35 (40.8) | 31 (24.1) |
| T classificationc | ||||
| T1a | 852 (35.4) | 812 (37.1) | 23 (25.9) | 17 (13.9) |
| T1b | 562 (22.3) | 519 (22.7) | 14 (14.6) | 29 (20.8) |
| T2 | 424 (16.8) | 392 (17.2) | 12 (12.5) | 20 (14.1) |
| T3/T4 | 579 (25.5) | 472 (23.0) | 41 (47.0) | 66 (51.2) |
| N classificationc | ||||
| N0 | 1859 (76.5) | 1750 (79.6) | 50 (54.1) | 59 (44.7) |
| N1 | 574 (23.5) | 452 (20.4) | 44 (45.9) | 78 (55.3) |
a
Unweighted number.
b
Weighted percentage (to compensate for differential probability of selection and survey nonresponse).
c
Derived from combined clinical and pathological tumor characteristics reported to SEER registries.
SEER, Surveillance, Epidemiology, and End Results.